Berberine derivative B4 alleviates ulcerative colitis via dual HSP60/NLRP3 targeting to restore mitochondrial homeostasis and suppress inflammasome activation

Journal of Pharmaceutical Analysis · Published 2026-08-01 · DOI 10.1016/j.jpha.2026.101743

Free full text

Authors (8)

Muyang Li, Baoqi Zhang, Xueni Ma, Songyang Yao, Xiongfei Luo, Dan Pu, Yingqian Liu, Dekui Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, M., Zhang, B., Ma, X., et al. (2026). Berberine derivative B4 alleviates ulcerative colitis via dual HSP60/NLRP3 targeting to restore mitochondrial homeostasis and suppress inflammasome activation. Journal of Pharmaceutical Analysis. https://doi.org/10.1016/j.jpha.2026.101743

Related articles